K

Kiniksa Pharmaceuticals Ltd
D

KNSA

26.935
USD
0.97
(3.72%)
مغلق
حجم التداول
32,289
الربح لكل سهم
0
العائد الربحي
-
P/E
-112
حجم السوق
1,965,472,996
أصول ذات صلة
A
ASND
2.290
(1.43%)
162.080 USD
ICLR
ICLR
1.130
(0.89%)
128.090 USD
M
MCRB
0.10000
(1.34%)
7.54000 USD
M
MGNX
-0.06500
(-4.13%)
1.51000 USD
O
OMER
-0.06000
(-1.87%)
3.15000 USD
R
RDFN
0.11000
(1.12%)
9.90000 USD
S
SGMO
-0.02030
(-4.11%)
0.47370 USD
TEVA
TEVA
-0.045
(-0.26%)
16.955 USD
VRTX
VRTX
1.79
(0.41%)
435.79 USD
المزيد
الأخبار المقالات

العنوان: Kiniksa Pharmaceuticals International plc

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.